Published on in Vol 13, No 1 (2021): Jan-Mar

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23011, first published .
Timothy Coetzee 1, MSc, PhD;  Mad Price Ball 2, PhD;  Marc Boutin 3, JD;  Abby Bronson 4, MBA;  David T Dexter 5, PhD;  Rebecca A English 6, MPH;  Patricia Furlong 7, BSN;  Andrew D Goodman 8, MD;  Cynthia Grossman 9, PhD;  Adrian F Hernandez 10, MD, MHS;  Jennifer E Hinners 11, MPH, MD;  Lynn Hudson 12, PhD;  Annie Kennedy 7, BSc;  Mary Jane Marchisotto 13, MBA;  Lynn Matrisian 14, PhD, MBA;  Elizabeth Myers 15, PhD;  W Benjamin Nowell 16, PhD;  Brian A Nosek 17, PhD;  Todd Sherer 18, PhD;  Carolyn Shore 6, PhD;  Ida Sim 19, PhD, MD;  Luba Smolensky 18, BA;  Christopher Williams 20, MSc;  Julie Wood 21, BA;  Sharon F Terry 22, MA, LhD

1 National Multiple Sclerosis Society , Cherry Hill, NJ, US

2 Open Humans Foundation , San Diego, CA, US

3 Novartis , Basel , CH

4 Edgewise Therapeutics , Boulder, CO, US

5 Parkinson’s UK , London , GB

6 National Academies of Sciences, Engineering, and Medicine , Washington, DC, US

7 Parent Project Muscular Dystrophy , Bethesda, MD, US

8 Department of Neurology, University of Rochester Medical Center , Rochester, NY, US

9 Biogen , Cambridge, MA, US

10 Duke University School of Medicine , Durham, NC, US

11 Bison Ink , Washington, DC, US

12 Critical Path Institute , Tucson, AZ, US

13 MJM Advisory, LLC , New York, NY, US

14 Pancreatic Cancer Action Network , Washington, DC, US

15 Doris Duke Charitable Foundation , New York, NY, US

16 Global Healthy Living Foundation , Upper Nyack, NY, US

17 Center for Open Science , Charlottesville, VA, US

18 The Michael J Fox Foundation for Parkinson’s Research , New York, NY, US

19 Department of Medicine, University of California San Francisco , San Francisco, CA, US

20 Multiple Myeloma Research Foundation , Norwalk, CT, US

21 Vivli , Columbia, MO, US

22 Genetic Alliance , Washington, DC, US

Corresponding Author: